<DOC>
	<DOCNO>NCT01365975</DOCNO>
	<brief_summary>Periconceptional folic acid supplement 400 ( Micro ) daily prevent neural tube defect ( NTD ) offspring . Some data suggest periconceptional folic acid supplement , folate level pregnancy , and/or certain variant gene encodes methylenetetrahydrofolate reductase ( MTHFR ) , key enzyme catalyze synthesis 5-methyltetrahydrofolate [ primary methyl donor metabolic pathway involve methylation include DNA methylation ] 5,10 methylenetetrahydrofolate may associate reduced risk certain adverse event prenatal period , birth weight certain serious disease offspring , study raise concern increase risk specific serious disorder . Only one study examine late health effect mother might associate use periconceptional folic acid supplement . We propose study potential health benefit adverse effect periconceptional folic acid supplement 15-year follow-up offspring mother . In offspring , evaluate whether periconceptional folic acid supplement reduce risk external congenital birth defect childhood acute lymphoblastic leukemia , whether risk reduce increase pediatric disorder link periconceptional folic acid supplement include asthma , pervasive developmental disorder autism , diabetes , obesity blood pressure . In mother , assess cardiovascular disease associate risk factor , breast colorectal cancer precursor condition , cancer . We also conduct exploratory assessment serious diseases mother . To increase limited data morbidity survival child born major birth defect , particularly low- middle-income country , plan assess morbidity mortality outcomes child identify neural tube defect part follow-up . The woman child participate joint China-U.S. Community Intervention Program ( CIP ) trial ( N=243,779 woman treat treated folic acid periconceptional period offspring ) represent unique cohort whose periconceptional exposure folic acid well document . We propose follow sample 22,000 CIP mother offspring ( currently 14 17 year age ) , ascertain vital status , medical history , lifestyle habit . The study clarify whether difference respect growth , physical development puberty period , select serious morbidity mortality offspring risk serious health outcome mortality mother associate periconceptional folic acid supplement . Data study inform u cohort participation rate , cost , effective approach future follow-up full cohort . The current protocol focus pilot study ( Pilot Study # 1 ) carry two specific aim 500 family . We test evaluate effective approach trace mother enrol CIP 1993-1995 CIP county , father , child . If child live biological mother , trace caretaker next kin child living . We also conduct in-person interview , obtain anthropometric blood pressure measurement determine cohort participation rate sample 500 CIP family two 21 CIP project county obtain health information , medical history , vital status . We attempt enroll pilot study 500 mothers/caretakers 500 offspring , 500 father ( Total N=1500 ) . Excluded Pilot Study # 1 time family mother child decease . We seek permission IRB enroll family later date .</brief_summary>
	<brief_title>Follow-up Study Late Effects Periconceptional Folic Acid Mothers Offspring Community Intervention Program Population : The Chinese Children Families Study</brief_title>
	<detailed_description>Periconceptional folic acid supplement 400 ( Micro ) daily prevent neural tube defect ( NTD ) offspring . Some data suggest periconceptional folic acid supplement , folate level pregnancy , and/or certain variant gene encodes methylenetetrahydrofolate reductase ( MTHFR ) , key enzyme catalyze synthesis 5-methyltetrahydrofolate [ primary methyl donor metabolic pathway involve methylation include DNA methylation ] 5,10 methylenetetrahydrofolate may associate reduced risk certain adverse event prenatal period , birth weight certain serious disease offspring , study raise concern increase risk specific serious disorder . Only one study examine late health effect mother might associate use periconceptional folic acid supplement . We propose study potential health benefit adverse effect periconceptional folic acid supplement 15-year follow-up offspring mother . In offspring , evaluate whether periconceptional folic acid supplement reduce risk external congenital birth defect childhood acute lymphoblastic leukemia , whether risk reduce increase pediatric disorder link periconceptional folic acid supplement include asthma , pervasive developmental disorder autism , diabetes , obesity blood pressure . In mother , assess cardiovascular disease associate risk factor , breast colorectal cancer precursor condition , cancer . We also conduct exploratory assessment serious diseases mother . To increase limited data morbidity survival child born major birth defect , particularly low- middle-income country , plan assess morbidity mortality outcomes child identify neural tube defect part follow-up . The woman child participate joint China-U.S. Community Intervention Program ( CIP ) trial ( N=243,779 woman treat treated folic acid periconceptional period offspring ) represent unique cohort whose periconceptional exposure folic acid well document . We propose follow sample 22,000 CIP mother offspring ( currently 14 17 year age ) , ascertain vital status , medical history , lifestyle habit . The study clarify whether difference respect growth , physical development puberty period , select serious morbidity mortality offspring risk serious health outcome mortality mother associate periconceptional folic acid supplement . Data study inform u cohort participation rate , cost , effective approach future follow-up full cohort . The current protocol focus pilot study ( Pilot Study # 1 ) carry two specific aim 500 family . We test evaluate effective approach trace mother enrol CIP 1993-1995 CIP county , father , child . If child live biological mother , trace caretaker next kin child living . We also conduct in-person interview , obtain anthropometric blood pressure measurement determine cohort participation rate sample 500 CIP family two 21 CIP project county obtain health information , medical history , vital status . We attempt enroll pilot study 500 mothers/caretakers 500 offspring , 500 father ( Total N=1500 ) . Excluded Pilot Study # 1 time family mother child decease . We seek permission IRB enroll family later date .</detailed_description>
	<mesh_term>Folic Acid</mesh_term>
	<mesh_term>Vitamin B Complex</mesh_term>
	<criteria>INCLUSION CRITERIA : 500 Chinese mother , father child age 1416 year Participated Community Intervention Program 1993 1996 Living Laoting Tai ( SqrRoot ) ( Beta ) ang Counties Provide consent The mother child provide answer least question himself/herself mother answer question child EXCLUSION CRITERIA : Not singleton birth Missing data pill usage Missing data gender</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>February 1, 2017</verification_date>
	<keyword>Cohort Study</keyword>
	<keyword>Folinic Acid , peri-conception</keyword>
	<keyword>Pediatric Leukemia</keyword>
	<keyword>Pediatric Cancer</keyword>
</DOC>